WHO ICTRP trial
Medicinal Cannabis for Endometriosis: The Gut Microbiome
ACTRN12624000828527 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12624000828527 |
|---|---|
| Public title | Medicinal Cannabis for Endometriosis: The Gut Microbiome |
| Scientific title | Exploring Medicinal Cannabis Effects on Endometriosis via Gut Microbiome Modulation: A Double-Blind Placebo-Controlled Clinical Trial |
| Primary sponsor | Western Sydney University |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Australia |
| Conditions | endometriosis; endometriosis;Reproductive Health and Childbirth - Menstruation and menopause;Alternative and Complementary Medicine - Other alternative and complementary medicine |
| Interventions | This trial will be testing two medicinal cannabis oil products (a CBD full spectrum oil and a THC:CBD balanced oil) that are potentially effective for the treatment of endometriosis- associated symptoms. The medication (in oil form) will be… |
| Registration date | Apr 7, 2024 |
| Target size | 42 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: